Why the study?
To evaluate whether pharmacologically inhibiting postprandial adipose tissue intracellular lipolysis with short-acting nicotinic acid increases adipose dietary fatty acid trapping and limits nonesterified fatty acid spillover to lean organs in prediabetes.
Does short-acting nicotinic acid increase adipose tissue dietary fatty acid trapping and reduce postprandial hepatic and cardiac fatty acid uptake in subjects with prediabetes?
Comparison
Short-acting nicotinic acid administration across four postprandial studies
Design
Physiological tracer study with PET/CT and stable isotopic tracers
Follow-up
6-h postprandial period
Authors
Loading...
Short-acting nicotinic acid enhances adipose tissue dietary fatty acid trapping and reduces postprandial hepatic and cardiac fatty acid uptake, potentially limiting lipotoxicity in prediabetes.
Does short-acting nicotinic acid increase adipose tissue dietary fatty acid trapping and reduce postprandial hepatic and cardiac fatty acid uptake in subjects with prediabetes?
Short-acting nicotinic acid enhances adipose tissue dietary fatty acid trapping and reduces postprandial hepatic and cardiac fatty acid uptake, potentially limiting lipotoxicity in prediabetes.
Montastier et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: